Longitudinal Gait and Balance Measurement

  • sponsor
    Friedreich’s Ataxia Research Alliance
Updated on 23 November 2020


Longitudinal Gait and Balance Measurement


A prospective longitudinal study, measuring gait and balance of ambulatory people with FRDA over a 12 month period of time, will be conducted. Gait and balance measures will be assessed at baseline, 6 months and 12 months.

Protocol Number: Gait and Balance study

Condition Friedreich's Ataxia
Clinical Study IdentifierTX141156
SponsorFriedreich’s Ataxia Research Alliance
Last Modified on23 November 2020


Yes No Not Sure

Inclusion Criteria

Diagnosis of FRDA, genetically documented to be due to homozygosity for a GAA repeat expansion in intron 1 of FXN
Aged 7 and above
Able to complete all the outcome measures safely as determined by the multidisciplinary team at the USF Ataxia Research Center and Human Functional Performance Laboratory
Able to ambulate independently without a gait aid during the baseline assessment

Exclusion Criteria

Compound heterozygotes for a GAA expansion in intron 1 and a point mutation in the FXN gene
Any injury or other medical condition limiting ability to weight-bear or ambulate that is not related to FRDA in the judgement of the investigator
Unable to walk independently without a gait aid
Aged under 7 years
Unable to complete all the outcome measures safely
Enrolled in a clinical trial during the baseline assessment and six month assessment
Anticipated to require a change in exercise regimen or require a non-standard or new therapeutic intervention for reduced mobility between the baseline and six month assessment as assessed by the multidisciplinary team at the USF Ataxia Research Center. This includes an inpatient admission or botulinum toxin injection
Recruitment will be monitored and if there are difficulties with recruitment, the ability to ambulate with a gait aid will be added to the eligibility criteria and exclusion criteria will be adjusted to allow inclusion of participants who are able to independently ambulate with a gait aid
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note